Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001144-23

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess if a switch from MMF to myfortic® results in improved GI- and/or health-related quality of life outcomes, and to determine the proportion of SPK transplant recipients who are experiencing any GI complaints under MMF-based immunosuppressive treatment.


Critère d'inclusion

  • Stable Pancreas-Kidney (SPK) Transplant Recipients

Liens